Many young women may be mistreating yeast infections, study finds
SKILLMAN, N.J. According to a recent survey of women ages 18 to 24 years commissioned by the Monistat brand, 61% of young women are unsure about which, if any, over-the-counter products can cure a yeast infection.
"Many women don’t realize that once they’ve identified they have a yeast infection, they can easily treat it on their own terms," stated Suzanne Gilberg-Lenz, a board-certified OB/GYN who practices in Beverly Hills, Calif., and a partner in the Monistat survey.
The survey also found more than 36% of women incorrectly believe that treating the symptoms of a yeast infection is the same as curing the infection. And 38% of women mistakenly believe a yeast infection only can be cured by a doctor’s prescription.
"The symptoms of a yeast infection vary greatly among individuals," Lenz said. "The classic symptoms … do not appear for all women. The important sign is always vaginal discomfort that develops out of the blue. If you are unsure, especially if you’ve never had a yeast infection, check with your doctor to make sure your symptoms aren’t actually the result of a sexually transmitted disease, bacterial infection or a combination of yeast and bacteria."
"If your yeast infection does not clear up, contact your doctor," Lenz added. "Once you’ve treated the infection, long-term, preventative measures, including changes to your diet and lifestyle, can help prevent future infections."
Watson gets FDA approval for generic Yasmin
MORRISTOWN, N.J. The Food and Drug Administration has approved a generic oral contraceptive made by Watson Pharmaceuticals, the drug maker said Tuesday.
Watson announced the FDA’s approval of Zarah (drospirenone and ethinyl estradiol tablets) in the 3 mg/0.03 mg strength. The drug is a generic version of Bayer’s Yasmin.
Watson said it has started shipping the drug, though Bayer’s patent litigation suit against the company concerning the drug remains pending in the U.S. District Court for the Southern District of New York.
Yasmin and generic versions had sales of around $97 million during the 12 months ended in June, according to IMS Health.
Periscope thinks pink with new lighted folio
RIDGEWOOD, N.J. A maker of deluxe e-reader covers has released a new version of its lighted folio.
Periscope released its new pink lighted folio in line with National Breast Cancer Awareness Month, the company said. Available for a suggested retail price of $49.95, the Periscope lighted folio is an “all-in-one” item that features a retractable Periscope twin LED reading light, deluxe cover and notebook/pen holder in one fashionably designed pink leatherette unit.
“With today’s debut of the pink lighted folio for both the [Amazon] Kindle 2 and [Barnes & Noble] Nook e-readers, and with National Breast Cancer Awareness Month occurring in October, we decided there was no better time to show our support of those whose lives have been affected by breast cancer,” Periscope president Eric Fisherman said. “The new pink lighted folio makes an ideal gift choice for gift-givers who wish to give a gift that has a greater significance. Now every time a consumer uses their pink lighted folio, they will be reminded of all those whose lives have been touched in any way by breast cancer.